Fidia S.p.A. (BIT:FDA)
Italy · Delayed Price · Currency is EUR 0.0088
+0.0002 (2.33%)
Sep 22, 2026, 5:35 PM CET
Fidia Employees
Fidia had 146 employees as of December 31, 2025. The number of employees decreased by 13 or -8.18% compared to the previous year.
Employees
146
Change
-13
Growth
-8.18%
Revenue / Employee
€209,329
Profits / Employee
€7,116
Market Cap
4.39M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 146 | -13 | -8.18% |
| Jun 30, 2025 | 140 | - | - |
| Dec 31, 2024 | 159 | -34 | -17.62% |
| Dec 31, 2023 | 193 | -4 | -2.03% |
| Dec 31, 2022 | 197 | - | - |
| Jun 30, 2020 | 289 | -42 | -12.69% |
| Mar 31, 2020 | 299 | -32 | -9.67% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Sep 30, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Danieli & C. Officine Meccaniche | 9,952 |
| Biesse | 3,601 |
| SIT S.p.A. | 1,916 |
| Tesmec | 937 |
| ILPRA | 422 |
| Marzocchi Pompe | 249 |
| OSAI Automation System | 222 |
| Clabo | 148 |
Fidia News
- 5 hours ago - Eledon Pharmaceuticals (ELDN) Shares Rise on Positive Tegoprubart Trial Data and FDA Fast Track - GuruFocus
- 8 hours ago - Woman held down, force-fed abortion pills at heart of ‘hell on earth’ fight over Biden-era policy - Fox News
- 10 hours ago - Filana Therapeutics (FLNA) Gains FDA Clearance to Resume Epilepsy Trial; Market Pricing ... - GuruFocus
- 10 hours ago - Blood, ketchup-stained ice, fake ghee: FDA suspends licences of 5 Mumbai establishments - The Times of India
- 10 hours ago - Compass Therapeutics (CMPX) Shares Plunge After FDA Calls for Additional Trial; Valuation ... - GuruFocus
- 11 hours ago - Compass Therapeutics (CMPX) Faces FDA Trial Recommendation Amidst Challenging Valuation - GuruFocus
- 11 hours ago - PALI Stock Update: Palisade Bio Gains FDA IND Approval for PALI-2108 Trial - GuruFocus
- 11 hours ago - Quoin Pharmaceuticals (QNRX) Gains FDA Fast Track for QRX003, Faces Valuation Challenges - GuruFocus